Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Artificial Cornea & Corneal Implant Market by Type (Artificial Cornea, Human Cornea), Disease Indication (Fuchs' Dystrophy, Fungal Keratitis, Keratoconus), End User - Forecast 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The global Artificial Cornea & Corneal Implant Market has witnessed remarkable growth and is projected to reach new heights from 2024 to 2030, according to a recent research publication. The comprehensive study aims to provide a holistic view of the market, considering the latest trends, competitive landscape, and regional market performance.
With an estimated market size of USD 528.79 million in 2023, and expected to rise at a CAGR of 12.65%, the potential market value is anticipated to hit USD 1,217.56 million by the end of 2030. This significant growth trajectory can be attributed to various key factors, including technological advancements, increasing demand for vision care, and growing incidence of corneal diseases.
In light of this expansion, the research publication provides an in-depth evaluation using the FPNV Positioning Matrix, categorizing vendors based on business strategy excellence and product satisfaction. Such critical assessments enable stakeholders to identify the forefront players and innovation pathfinders in the Artificial Cornea & Corneal Implant space.
An intricate Market Share Analysis within the report delivers insights into vendor performance, based on revenue and customer base comparisons. Analyses of accumulation, fragmentation, dominance, and amalgamation characteristics offer strategic intelligence necessary for understanding market dynamics.
Key company profiles featured in the study spotlight organisations like AbbVie Inc., and Bausch & Lomb Incorporated, among others, showcasing their recent strategic moves and product development prowess. This research encapsulates the market segmentation detailing sub-markets such as Artificial Cornea, Human Cornea, Fuchs' Dystrophy, and Keratoconus by type and disease indication respectively.
Key Insights and Forecasts for Stakeholders
- Comprehensive analysis of potential market penetration opportunities for emerging and established players.
- Deep dive into market development trends that facilitate informed decision-making for geographic and product diversification.
- Competitive assessments elucidating market shares, innovative product launches, and operational capabilities of industry leaders.
- Forecasting and innovation outlook to anticipate future technology shifts and R&D directions.
The study systematically answers vital questions for participants, ranging from market size and top investment pockets to technology trends and regulatory landscapes. Offering an overarching view, the report is a significant tool for entities aiming to enter or expand within the Artificial Cornea & Corneal Implant Market.
By delivering unparalleled business insights, this research stands to aid stakeholders in capitalizing on market opportunities and devising strategies that align with both current and future industry developments.
Key Topics Covered:
- Market Insights
- Understanding the Artificial Cornea & Corneal Implant Market
- Market Dynamics: Drivers, Restraints, Opportunities, and Challenges
- Trend Analysis and Cumulative Impact of High Inflation
- Market Segmentation
- Analysis of Market Segments and Trends
- Types: Artificial Cornea vs. Human Cornea
- Disease Indications: Fuchs' Dystrophy, Fungal Keratitis, Keratoconus
- Regional Analysis
- Americas, Asia-Pacific, Europe, Middle East & Africa Markets
- Insights on Regional Trends and Market Dynamics
- Competitive Landscape
- FPNV Positioning Matrix
- Market Share Analysis and Competitive Scenario
- Key Players and their Competitive Portfolio
- Future Outlook
- Emerging Opportunities and Market Projections
- Regulatory Framework and Industry Trends
Key Attributes
| Report Attribute | Details |
| No. of Pages | 191 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $593.13 Million |
| Forecasted Market Value (USD) by 2030 | $1217.56 Million |
| Compound Annual Growth Rate | 12.6% |
| Regions Covered | Global |
Companies Mentioned
- AbbVie Inc.
- Addition Technology Inc.
- Advancing Sight Network
- AJL Ophthalmic S.A.
- Allotex, Inc.
- Aurolab
- Bausch & Lomb Incorporated
- Beijing Microkpro Medical Instrument Co., Ltd
- Cornea Biosciences Inc.
- CorneaGen Inc.
- CorNeat Vision Ltd.
- DIOPTEX GmbH
- Eye Bank Association of America
- EyeYon Medical Ltd.
- F. Hoffmann-La Roche Ltd.
- Florida Lions Eye Bank
- KeraMed, Inc.
- L V Prasad Eye Institute
- LinkoCare Life Sciences AB
- Mediphacos
- MIOK Keratoprosthesis
- Pfizer, Inc.
- Presbia PLC
- SMR Ophthalmic
- The Cooper Companies, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/4000d6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
